Macrogenics (MGNX) Competitor Comparison
We are evaluating the key criteria listed to compare Macrogenics (MGNX) against its competitors in the Biotechnology industry.
Market Capitalization
123 / 368Gross Profits
208 / 278Total Revenue
83 / 300EBITDA
197 / 337Free Cashflow
209 / 352Quick Ratio
174 / 357Earnings per Share
174 / 359Dividend yield
0 / 6Total Cash
128 / 358Performance 3 years
245 / 368Performance 5 years
179 / 368Performance 10 years
218 / 368Linearity 3 years
210 / 368Linearity 5 years
64 / 368Linearity 10 years
144 / 368Total Rank
188 / 368Dividend Rank
194 / 368Valuation Rank
83 / 368Piotroski Rank
92 / 368Muliplier Rank
147 / 368Gross Profits - MGNX ranking 208 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.